http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109529017-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2018-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109529017-B |
| titleOfInvention | Application of annexin V |
| abstract | The invention belongs to the technical field of biology, and particularly discloses an application of annexin V in preparation of a medicine for delaying the progress of diabetes, which specifically comprises the following steps: the application of the medicine in preparing the medicine for improving the physiological indexes and the metabolic condition of diabetes, improving the insulin signal path of a diabetes model, improving the pathological changes of the liver, the pancreas and the kidney of diabetes, improving the serum creatinine and the urea nitrogen level of the diabetes, preventing diabetic kidney complications or renal function damage and protecting insulinoma cells from apoptosis caused by diabetes inducer streptozotocin. |
| priorityDate | 2018-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 113.